StockData
GE HealthCare Technologies Inc. logo

GE HealthCare Technologies Inc. (GEHC) stock

GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 15/3011% below fair value
$81.84−1.12 (-1.35%)

Close on Nov 17, 2026Market cap $37.00BP/E 17.3Yield 0.17%

How the market prices GE HealthCare Technologies

Each ratio against its own distribution since 2022, from month-end prices and the figures reported at the time

GE HealthCare Technologies trades at 17.3× its earnings, against a median of 18.7× since 2022 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2022, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2022

Median 18.7×, today 17.3×

What GE HealthCare Technologies keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin39.9%vs 55.4%
Operating margin13.3%vs -5.17%
EBITDA margin13.3%vs -2.67%
Pretax margin12.8%vs -2.76%
Net margin9.96%vs -10.3%
Free cash flow margin8.73%vs 0.40%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity19.9%vs -16.3%
Return on assets5.78%vs -12.2%
Return on invested capital12.4%vs -4.33%
Return on capital employed9.76%vs -8.99%

How hard the assets work

Revenue per dollar of assets0.58vs 0.58
Inventory turns a year5.27vs 2.23
Revenue per employee$400.69Kvs $328.95K
Profit per employee$39.89Kvs -$48.85K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $7.15B, or 2.5 times a year of EBITDA. That is 16.2% of the $44.17B it would cost to buy the business outright.

Total debt$9.98B
Cash and short-term investments$2.83B
EBITDA, trailing twelve months$2.89B
Free cash flow, trailing twelve months$1.89B

Leverage and liquidity

Debt to equity0.86vs 0.42
Debt to EBITDA3.46vs 2.47
Net debt to EBITDA2.48vs 1.49
Debt to free cash flow5.28vs 3.66
Current ratio1.30vs 2.50
Quick ratio0.32vs 1.55

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

1.98
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

5 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $52.34Price $81.84

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield5.82%vs -5.30%
Free cash flow yield5.10%vs 0.20%
Dividend yield0.17%vs 0.79%
Buyback yield0.81%vs 0.67%
Shareholder yield0.98%vs 0.88%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Dividends out of earnings

3%
Room to spareMost of itMore than it makes

Dividends out of free cash flow

3%
Room to spareMost of itMore than it makes

The dividend has risen for 2 straight fiscal years, to $0.14 a share.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$58.7552-week low52-week high$89.77
200-day50-day20-day$81.84

The close sits 74% of the way up the 52-week range, 8.8% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

63
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

GEHCS&P 500
PeriodGEHCS&P 500DifferenceGEHC per yearS&P 500 per year
1 month+17.7%-4.0%+21.7 pts
3 months+13.1%-5.0%+18.1 pts
Year to date-0.0%+8.2%−8.3 pts
1 year+16.1%+11.2%+4.9 pts
3 years+12.7%+68.5%−55.8 pts+4.1%+19.0%

How much it moves

Volatility, 1 year35.8%vs 64.9%
Volume against its 90-day average0.71vs 0.87

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

18M GEHC shares were sold short on Oct 30, 2026, down 5.8% from the previous report, or 4.05% of the shares available to trade. At recent volumes it would take 4.9 days to buy them back. Over the last 20 sessions, 47.9% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float4.05%vs 5.08%
Short interest as a share of all shares4.04%vs 3.88%
Days of volume to buy it back4.87vs 3.94

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202618,256,312-5.8%3,751,2844.9
Oct 15, 202619,374,350+4.6%3,777,5235.1
Sep 30, 202618,520,401+9.5%3,962,3194.7
Sep 15, 202616,909,543-10.8%3,051,8695.5
Aug 31, 202618,955,374+8.8%2,528,3907.5
Aug 14, 202617,427,194-10.1%2,959,3885.9
Jul 31, 202619,385,482+5.1%6,584,5322.9
Jul 15, 202618,451,068+28.4%4,786,1163.9
Jun 30, 202614,368,819-7.7%5,670,4052.5
Jun 15, 202615,575,836+6.2%4,347,0373.6
May 29, 202614,670,393+20.5%4,990,2992.9
May 15, 202612,176,506+1.0%6,137,2132.0

Every measure, in full

102 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 3, 2027 (estimated, before the open)
Last ex-dividend date
Oct 23, 2026
Fundamentals through
Sep 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$37.00B
$486.03M
Enterprise Value
$44.17B
$423.26M
PE Ratio
17.27
31.93
PS Ratio
1.71
2.99
PB Ratio
3.19
3.11
P/FCF Ratio
19.59
26.77
P/OCF Ratio
15.32
21.63

Enterprise valuationIndustry

EV / Sales
2.04
2.87
EV / EBITDA
15.30
19.16
EV / EBIT
15.30
24.40
EV / FCF
23.38
28.94

Share statisticsIndustry

Shares Change (YoY)
-0.60%
3.51%
Float
451M
38M
Shares Held by Insiders
0.33%
10.4%
Shares Held by Institutions
87.2%
60.2%

Short sellingIndustry

Short Interest
18M
–
Short Interest Change
-5.77%
-2.57%
Short % of Float
4.05%
5.08%
Short % of Shares Outstanding
4.04%
3.88%
Days to Cover
4.87
3.94

Stock price statisticsIndustry

52-Week High
$89.77
–
52-Week Low
$58.75
–
20-Day Moving Average
$78.79
–
50-Day Moving Average
$71.13
–
200-Day Moving Average
$69.96
–
Average True Range (14)
$2.24
–
Price Change (1 Week)
-2.16%
-5.23%
Price Change (1 Month)
17.3%
-4.69%
Price Change (3 Months)
9.68%
-10.9%
Price Change (6 Months)
32.9%
-5.88%
Price Change (YTD)
-0.22%
-6.19%
Price Change (1 Year)
11.9%
-2.64%
Price Change (3 Years)
12.1%
-2.24%
Average Volume (10 Days)
4M
–
Average Volume (20 Days)
4M
–
Average Volume (90 Days)
4M
–
Relative Volume
0.71
0.87
Relative Strength Index (14)
63.4
44.0
Volatility (1 Year)
35.8%
64.9%

MarginsIndustry

Gross Margin
39.9%
55.4%
Operating Margin
13.3%
-5.17%
Pretax Margin
12.8%
-2.76%
Profit Margin
9.96%
-10.3%
EBITDA Margin
13.3%
-2.67%
FCF Margin
8.73%
0.40%

Returns on capitalIndustry

Return on Equity (ROE)
19.9%
-16.3%
Return on Assets (ROA)
5.78%
-12.2%
Return on Invested Capital (ROIC)
12.4%
-4.33%
Return on Capital Employed (ROCE)
9.76%
-8.99%

Financial positionIndustry

Current Ratio
1.30
2.50
Quick Ratio
0.32
1.55
Debt / Equity
0.86
0.42
Debt / EBITDA
3.46
2.47
Debt / FCF
5.28
3.66
Net Debt / EBITDA
2.48
1.49

GrowthIndustry

Revenue Growth (YoY)
6.87%
9.06%
Net Income Growth (YoY)
-2.84%
10.3%
EPS Growth (YoY)
-2.07%
12.5%
FCF Growth (YoY)
34.9%
9.29%
Revenue Growth (3Y CAGR)
3.99%
7.08%
EPS Growth (3Y CAGR)
2.54%
3.11%

EfficiencyIndustry

Asset Turnover
0.58
0.58
Inventory Turnover
5.27
2.23
Revenue Per Employee
$400.69K
$328.95K
Profits Per Employee
$39.89K
-$48.85K
Employee Count
54,000
193

Income statement (TTM)Industry

Revenue
$21.64B
$104.77M
Gross Profit
$8.64B
$61.99M
Operating Income
$2.89B
-$3.82M
Pretax Income
$2.77B
-$2.12M
Net Income
$2.15B
-$6.19M
EBITDA
$2.89B
-$2.02M
EPS (Diluted)
$4.74
-$0.08

Balance sheetIndustry

Total Debt
$9.98B
$99.39M
Net Cash (Debt)
-$7.15B
$3.73M
Net Cash Per Share
-$15.81
$0.28
Equity (Book Value)
$11.61B
$63.83M
Book Value Per Share
$25.69
$2.98
Tangible Book Value
-$5.34B
$10.75M
Working Capital
$2.68B
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
$2.42B
-$463.66K
Capital Expenditures
-$526.00M
-$3.69M
Free Cash Flow
$1.89B
-$407.03K
FCF Per Share
$4.18
-$0.01

Dividends and yieldsIndustry

Earnings Yield
5.82%
-5.30%
FCF Yield
5.10%
0.20%
Dividend Yield
0.17%
0.79%
Buyback Yield
0.81%
0.67%
Shareholder Yield
0.98%
0.88%
Dividend Per Share
$0.14
$0.72
Dividend Growth (YoY)
12.0%
4.80%
Years of Dividend Growth
2
0
Payout Ratio
2.97%
27.5%
FCF Payout Ratio
3.39%
22.4%

Taxes and interestIndustry

Income Tax
$561.00M
$1.52M
Effective Tax Rate
20.2%
19.0%

Scores and fair valueIndustry

Graham Number
$52.34
$34.74
Graham Upside
-36.0%
-61.3%
Altman Z-Score
1.98
2.40
Piotroski F-Score
5
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?